ABBVVSTMO• 28 Days (Normalized)
ABBV vs TMO (AbbVie Inc. vs Thermo Fisher Scientific Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ABBV Performance $271.36
+6.42%
AbbVie Inc.
Normalized Baseline0.00%
TMO Performance $662.06
+9.76%
Thermo Fisher Scientific Inc.
Normalized Baseline0.00%
Alpha Spread Margin TMO LEADS
-3.34 pts
TMO outperforming by 3.34 percentage points
ABBVTMO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ABBV TMO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ABBV Price | ABBV Gain (%) | TMO Price | TMO Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $271.36 | +6.42% | $662.06 | +9.76% | -3.34% |
| Oct 06, 2026 | $266.69 | +4.58% | $656.58 | +8.85% | -4.27% |
| Oct 05, 2026 | $265.76 | +4.22% | $676.76 | +12.20% | -7.98% |
| Oct 02, 2026 | $262.82 | +3.07% | $654.80 | +8.56% | -5.49% |
| Oct 01, 2026 | $259.93 | +1.93% | $- | - | |
| Sep 30, 2026 | $261.59 | +2.58% | $676.08 | +12.09% | -9.51% |
| Sep 29, 2026 | $263.29 | +3.25% | $679.61 | +12.67% | -9.42% |
| Sep 28, 2026 | $266.28 | +4.42% | $678.60 | +12.50% | -8.08% |
| Sep 25, 2026 | $264.34 | +3.66% | $675.00 | +11.91% | -8.25% |
| Sep 24, 2026 | $- | $678.39 | +12.47% | - | |
| Sep 23, 2026 | $265.08 | +3.95% | $665.30 | +10.30% | -6.35% |
| Sep 22, 2026 | $265.21 | +4.00% | $658.52 | +9.17% | -5.17% |
| Sep 21, 2026 | $264.48 | +3.72% | $658.76 | +9.21% | -5.49% |
| Sep 18, 2026 | $263.96 | +3.51% | $651.45 | +8.00% | -4.49% |
| Sep 17, 2026 | $264.02 | +3.54% | $658.32 | +9.14% | -5.60% |
Page 1 of 2